Decoding the RNA Operating System of the Cell with the Most Up-to-date miRNA Profiling Service

febit’s new microRNA profiling services can make researchers stay ahead in microRNA research

Heidelberg, (PresseBox) - febit biotech gmbh, a leading supplier of flexible microarray technology today announced the launch of its new miRNA profiling service. With day-to-day synthesis capability and broad flexibility of content, febit’s Geniom Biochips reflect the most up-to-date version of miRBase, the miRNA database at the Sanger Institute. In addition the biochip content is completely customizable to include capture probes for researchers own miRNA targets.

The customer can choose the degree of autonomy he needs and use three types of services:
1. Preset Geniom miRNA Biochip which is based on the latest miRBase Version 10.0, 2. the same biochip plus some sequences specified by the customer, or 3. a biochip which contains completely customized oligonucleotides for microarray analysis. miRNA profiling can be put out as a service which is offered by febit, or can be analyzed independently by ordering Geniom Ready-to-Go Biochips or even use the possibility to buy the Geniom Platform to produce up-to-date biochips in the researcher’s lab.

Ph.D. Adam Grundhoff from the Heinrich-Pette-Institute for Experimental Virology and Immunology at the University of Hamburg (Germany) stated: “For our evaluation studies we used preset Geniom Biochips based on the miRBase Version 10.0 content with additional viral sequences which are relevant for our research. The chips were analyzed with our samples by febit and we are very excited about the short handling time and the high quality results.”

Detailed information about these services are available at www.mirna-profiling.com.

Hummingbird Diagnostics GmbH

Developing innovative and creative technologies for genomic research is the corporate mission of the febit group, a German-American biotech company. Geniom is a technological and service platform successfully used in basic and applied research of renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes providing superior time and cost efficiency combined with an unsurpassed spectrum of applications (Geno-, SNP- and Pathogentyping, Enzyme-on-Chip, miRNA-Profiling and many more). With the unique Geniom Technology febit now enters the high-potential market of synthetic biology with a novel method for production of synthetic genes. Using both, highly integrated automation and extensive customizability, febit meets essential needs of current biomedical research.

www.febit.com

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.